The chemotherapeutic agent VP16 increases the stability of HB-EGF mRNA by a mechanism involving the 3â²-UTR
Keywords: AR; amphiregulin; HB-EGF; heparin binding epidermal growth factor like growth factor; EPI; epiregulin; EGF; epidermal growth factor; BETA; betacellulin; TGFα; transforming growth factor α; HER; human EGF receptor; 3â²-UTR; 3â²-untranslated region; ARE